ABSTRACT

The coronavirus 2019 (COVID-19) pandemic has affected millions around the world. The severe form of the disease is associated with respiratory distress and thromboembolic manifestations. Inflammatory markers like C reactive protein (CRP) and D dimer have an independent effect on disease severity and carry prognostic importance and outcomes. We describe a series of four cases of COVID-19 patients who had unusual manifestations of thrombosis. The sole aim is to bring forward the atypical causes and manifestations of COVID induced thrombotic events. Our Case Series showed rare thrombotic presentations in patients with COVID 19 with the use of immunomodulators, prolonged ICU stays with few having thrombotic events as sole presentation. Keywords: COVID-19 infection, COVID thrombosis, Immunomodulators
Publication date: 01/10/2022

https://ijbpas.com/pdf/2022/October/MS_IJBPAS_2022_6511.pdf

Download PDF
https://doi.org/10.31032/IJBPAS/2022/11.10.6511